Vimarsana
Biggest News Aggregation in the World

Arthurc Corcoran News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arthurc Corcoran. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arthurc Corcoran Today - Breaking & Trending Today

New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the European Society of Hypertension Annual Meeting 2023 - Vimarsana News

New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the European Society of Hypertension Annual Meeting 2023

Allschwil, Switzerland – June 26, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia’s investigational dual endothelin receptor antagonist evaluating the treatment of patients with resistant hypertensio...

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 () - Vimarsana News

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 ()

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 () | aktiencheck.de

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 - Vimarsana News

GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202

^Allschwil, Switzerland - June 23, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia's investigational dual endothelin receptor antagonist evaluating the treatment of patients with resistant hypertension, will be presented as an oral presentation by Prof. M...

New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 - Vimarsana News

New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202

Allschwil, Switzerland – June 23, 2023 Idorsia Ltd (SIX: IDIA) today announced that further data for aprocitentan, Idorsia’s investigational dual endothelin receptor antagonist evaluating the

Börse Express - GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202 - Vimarsana News

Börse Express - GNW-Adhoc: New Phase 3 data with aprocitentan to be presented at the European Society of Hypertension Annual Meeting 202

^Allschwil, Switzerland - June 23, 2023